Cooper Companies (NYSE:COO) Price Target Increased to $300.00 by Analysts at Raymond James

Share on StockTwits

Cooper Companies (NYSE:COO) had its price target raised by research analysts at Raymond James from $270.00 to $300.00 in a note issued to investors on Friday, September 21st. The brokerage currently has an “outperform” rating on the medical device company’s stock. Raymond James’ price objective indicates a potential upside of 17.09% from the stock’s previous close.

COO has been the topic of several other reports. Oppenheimer set a $265.00 price objective on shares of Cooper Companies and gave the stock a “hold” rating in a research report on Friday, June 8th. Zacks Investment Research upgraded shares of Cooper Companies from a “sell” rating to a “hold” rating in a research report on Wednesday, September 12th. ValuEngine lowered shares of Cooper Companies from a “hold” rating to a “sell” rating in a report on Wednesday, June 6th. TheStreet upgraded shares of Cooper Companies from a “c+” rating to a “b-” rating in a report on Friday, June 15th. Finally, BMO Capital Markets upped their target price on shares of Cooper Companies from $280.00 to $285.00 and gave the company an “outperform” rating in a report on Friday, August 31st. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $274.11.

COO traded up $5.63 during trading on Friday, hitting $256.22. The stock had a trading volume of 302,292 shares, compared to its average volume of 413,819. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58. The stock has a market capitalization of $13.62 billion, a P/E ratio of 26.41, a P/E/G ratio of 2.22 and a beta of 0.67. Cooper Companies has a twelve month low of $216.47 and a twelve month high of $280.10.

Cooper Companies (NYSE:COO) last posted its quarterly earnings results on Thursday, August 30th. The medical device company reported $3.00 earnings per share for the quarter, missing the Zacks’ consensus estimate of $3.07 by ($0.07). Cooper Companies had a return on equity of 17.53% and a net margin of 5.23%. The company had revenue of $660.00 million for the quarter, compared to analyst estimates of $653.44 million. Sell-side analysts predict that Cooper Companies will post 11.62 EPS for the current year.

In related news, Director Robert S. Weiss sold 58,543 shares of the firm’s stock in a transaction on Wednesday, September 5th. The stock was sold at an average price of $252.82, for a total transaction of $14,800,841.26. Following the transaction, the director now directly owns 157,710 shares in the company, valued at $39,872,242.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Allan E. Rubenstein sold 1,500 shares of the firm’s stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $265.37, for a total value of $398,055.00. Following the transaction, the director now owns 3,068 shares in the company, valued at $814,155.16. The disclosure for this sale can be found here. Insiders sold 80,809 shares of company stock valued at $20,740,667 in the last ninety days. 1.60% of the stock is owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. BlackRock Inc. lifted its stake in Cooper Companies by 0.9% in the first quarter. BlackRock Inc. now owns 3,647,931 shares of the medical device company’s stock valued at $834,681,000 after buying an additional 31,592 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Cooper Companies by 11.8% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,054,418 shares of the medical device company’s stock valued at $719,163,000 after buying an additional 323,559 shares during the last quarter. Janus Henderson Group PLC lifted its stake in Cooper Companies by 23.8% in the second quarter. Janus Henderson Group PLC now owns 2,618,690 shares of the medical device company’s stock valued at $616,595,000 after buying an additional 502,783 shares during the last quarter. Frontier Capital Management Co. LLC lifted its stake in Cooper Companies by 18.0% in the second quarter. Frontier Capital Management Co. LLC now owns 825,561 shares of the medical device company’s stock valued at $194,378,000 after buying an additional 126,101 shares during the last quarter. Finally, Bessemer Group Inc. increased its holdings in shares of Cooper Companies by 17.8% during the second quarter. Bessemer Group Inc. now owns 755,727 shares of the medical device company’s stock valued at $177,935,000 after purchasing an additional 113,964 shares during the period. Institutional investors own 97.07% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Article: What does EPS mean?

Analyst Recommendations for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.